Genenta Science S.p.A. (GNTA): Broker Consensus Forecast

This daily price chart for Genenta Science S.p.A. (GNTA) allows for an assessment of how strict FDA oversight and patent restrictions impact asset value, where the indicator reaches 6.91. The business focuses on developing treatments for solid tumors by modifying a patient's own cells. The model's efficiency is supported by a complex biomaterial transport system to specialized clinics that maintains strict temperature controls.

GNTA - genenta.com Analyst Consensus Forecast over the range 07/04/2022 - 11/04/2026

Metric breakdowns and analytics for Genenta Science S.p.A. (GNTA)

- market value and analyst target forecast:

Price Rate Chart genenta.com|GNTA - Price Target Chart

- stock exchange capitalization data:

Market Capitalization Genenta|GNTA - Real Price to Acquire Entire Company

- business book valuation details:

Book Price of a Share Genenta Science|GNTA - Book Capitalization|Market Capitalization to Book Value Ratio genenta.com|GNTA - Aggregate Company Assets

- business debt structure and liquidity details:

- earnings and market ratios statistics:

GNTA - Company Net Income|Expected Net Profit Genenta Science S.p.A.|GNTA - P/E Multiple|Forward Price to Earnings Multiple genenta.com|GNTA - Price/Earnings to Growth Multiple|Company Value to EBITDA Genenta|GNTA - Operating profit before deduction of amortization|Earnings per share for the trailing year Genenta Science|GNTA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months genenta.com|GNTA - Earnings growth in current year|Expected net earnings per share growth next year Genenta Science S.p.A.

General company analysis:GNTA (Genenta Science SpA)

Mass-produced product of Genenta Science SpA

Utilizing this metric allows investors to filter out market noise and test the resilience of long positions through aggregated expert expectations of fair value. Amid geopolitical risks for Genenta Science S.p.A. that hinder international gene research, the average market price target serves as a filter to determine whether the business retains its fundamental growth potential despite operational disruptions.

Competitors of Genenta Science S.p.A.